The AUH Gene 3-Methylglutaconic Aciduria Type 1 Genetic Test is a specialized diagnostic tool designed to detect mutations in the AUH gene, which are responsible for 3-Methylglutaconic Aciduria Type 1, a rare metabolic disorder. This condition is characterized by the body's inability to properly process certain proteins, leading to an accumulation of 3-methylglutaconic acid and related compounds in the body. Symptoms can vary but may include developmental delay, intellectual disability, and other neurological or physical issues.
Performed at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify mutations in the AUH gene that indicate the presence of 3-Methylglutaconic Aciduria Type 1. The test is critical for early diagnosis, which can aid in managing symptoms and improving the quality of life for affected individuals.
The cost of the AUH Gene 3-Methylglutaconic Aciduria Type 1 Genetic Test is 4400 AED. This investment covers the sophisticated procedures required to accurately identify the genetic mutations associated with this condition. Given the complexity and the specialized nature of this test, it is conducted in the highly equipped and technologically advanced facilities of DNA Labs UAE, ensuring accurate and reliable results for patients and their families.
The OPA3 Gene 3-Methylglutaconic Aciduria Type 3 Genetic Test is a specialized diagnostic tool designed to identify mutations in the OPA3 gene, which are associated with the rare metabolic disorder known as 3-Methylglutaconic Aciduria Type 3 (MGCA3). This condition is characterized by a spectrum of symptoms, including vision loss, movement disorders, and neurological deficits, which result from the accumulation of 3-methylglutaconic acid and related metabolites in the body due to a deficiency in mitochondrial function.
DNA Labs UAE offers this genetic test as part of its comprehensive suite of diagnostic services, providing a crucial resource for individuals and families seeking answers to complex genetic conditions. By analyzing a sample of the patient's DNA, the test can confirm the presence of specific mutations in the OPA3 gene, thus aiding in the diagnosis of MGCA3. This information is vital for understanding the risk of disease transmission, guiding treatment decisions, and enabling personalized medical care.
The cost of the OPA3 Gene 3-Methylglutaconic Aciduria Type 3 Genetic Test at DNA Labs UAE is 4400 AED. While the price may be a consideration for some, the value of obtaining a definitive diagnosis and the potential to tailor interventions specifically to an individual's genetic makeup can be immeasurable for affected families.
The DNAJC19 gene test for 3-Methylglutaconic Aciduria Type 5 is a genetic test offered by DNA Labs UAE, designed to identify mutations in the DNAJC19 gene, which are associated with the development of 3-Methylglutaconic Aciduria Type 5. This condition is a rare, inherited metabolic disorder characterized by a variety of symptoms including neurological impairments, heart problems, and growth delays. The DNAJC19 gene plays a crucial role in the maintenance of mitochondrial function, and mutations can lead to disrupted energy production within cells.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed in the laboratory to detect any genetic variations in the DNAJC19 gene that are known to cause 3-Methylglutaconic Aciduria Type 5. The results from this test can provide essential information for the diagnosis and management of the disorder, allowing for personalized treatment plans and informing family planning decisions. DNA Labs UAE ensures confidentiality and accuracy in the testing process, offering support and guidance throughout the testing procedure.
The SERAC1 gene test for 3-Methylglutaconic Aciduria with Deafness, Encephalopathy, and Leigh-like Syndrome is a comprehensive genetic analysis aimed at diagnosing this complex condition. This disorder, often abbreviated as MEGDEL syndrome, is a rare genetic condition characterized by high levels of 3-methylglutaconic acid in the urine, sensorineural deafness, developmental delays, and symptoms associated with Leigh syndrome, such as neurological deficits and weakened muscle tone.
The test specifically looks for mutations in the SERAC1 gene, which have been linked to the development of MEGDEL syndrome. By analyzing the DNA sequence of the SERAC1 gene, healthcare providers can confirm a diagnosis, allowing for early intervention and management of the condition. This is crucial for improving the quality of life for affected individuals, as the syndrome can significantly impact neurological and physical development.
The test is available at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. The cost of the test is 4400 AED, reflecting the sophisticated nature of the analysis and the specialized expertise required to interpret the results. Given the rarity of the condition and the complexity of the genetic analysis, the test represents a significant step forward in the personalized care of patients with rare genetic disorders.
**CAT Gene Acatalasemia Genetic Test**
The CAT Gene Acatalasemia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CAT gene responsible for acatalasemia, also known as acatalasia. This condition is characterized by the absence or significant reduction of catalase activity within red blood cells, leading to various health issues, including oral gangrene and increased susceptibility to infections due to the inability to break down hydrogen peroxide.
This genetic test is crucial for individuals with a family history of acatalasemia or those exhibiting symptoms related to catalase deficiency. Early detection through this test allows for timely management and preventive measures to mitigate potential health complications associated with the condition.
The test is conducted in a state-of-the-art laboratory setting by DNA Labs UAE, ensuring high accuracy and reliability of results. The cost of the CAT Gene Acatalasemia Genetic Test is set at 4400 AED, reflecting the comprehensive analysis and expertise involved in diagnosing this genetic disorder.
The ACHE Gene Acetylcholinesterase Deficiency Genetic Test is a specialized diagnostic tool designed to identify mutations in the ACHE gene, which is responsible for encoding the enzyme acetylcholinesterase. This enzyme plays a crucial role in nerve function by breaking down acetylcholine, a neurotransmitter essential for muscle activation and the transmission of signals in the nervous system. Deficiencies or malfunctions in acetylcholinesterase can lead to various neurological disorders and symptoms, making it imperative to detect any genetic anomalies accurately.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers individuals the chance to understand their genetic makeup concerning the ACHE gene. With a cost of 4400 AED, the test is a significant investment in personal health, providing valuable insights that can guide medical professionals in developing personalized treatment plans or preventive measures for conditions associated with acetylcholinesterase deficiency. DNA Labs UAE utilizes advanced genetic sequencing technologies to ensure precise and reliable test results, offering clients peace of mind and a path towards informed health decisions.
The ACADM gene encodes the enzyme medium-chain acyl-CoA dehydrogenase (MCAD), which plays a crucial role in the metabolism of medium-chain fatty acids within the mitochondria. Deficiencies in this enzyme can lead to a condition known as Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD), a metabolic disorder that prevents the body from converting certain fats into energy, particularly during fasting or illnesses. This can lead to various symptoms, including hypoglycemia, lethargy, and even life-threatening complications if not diagnosed and managed properly.
The genetic test for ACADM gene mutations is a critical tool in diagnosing MCADD, allowing for early intervention and management strategies to be implemented, thereby significantly reducing the risk of complications. This test involves analyzing the DNA to identify mutations in the ACADM gene that are known to cause the disorder.
At DNA Labs UAE, the genetic test for ACADM Gene Acyl-CoA Medium-Chain Dehydrogenase Deficiency is available for 4400 AED. This comprehensive test is performed in a state-of-the-art laboratory facility by skilled professionals, ensuring accurate and reliable results. The cost encompasses the full testing process, from sample collection to the analysis and reporting of results. Given the potential severity of MCADD, this test is an invaluable resource for at-risk individuals, offering a pathway to early detection and management of the condition.
The "ETFA Gene Acyl-CoA Multiple Dehydrogenase Deficiency Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the ETFA gene. These mutations are responsible for a condition known as Multiple Acyl-CoA Dehydrogenase Deficiency (MADD), also referred to as Glutaric Acidemia Type II. MADD is a metabolic disorder that affects the body's ability to break down certain fats and proteins, leading to a range of symptoms from mild to severe, including metabolic crises.
The test specifically targets the ETFA gene, one of the genes involved in the electron transfer flavoprotein complex, crucial for the proper function of the mitochondrial respiratory chain. Mutations in this gene disrupt normal metabolism, leading to the accumulation of fatty acids and organic acids in the body, which can be toxic and lead to the symptoms associated with MADD.
DNA Labs UAE offers this genetic test at a cost of 3200 AED. The test is conducted through a simple blood sample, where DNA is extracted and analyzed for mutations in the ETFA gene. This genetic testing is crucial for early diagnosis, which can significantly improve the management and prognosis of the condition. Early intervention with dietary management and, in some cases, supplements or medications can help manage the symptoms and prevent metabolic crises.
Families with a history of MADD or individuals showing symptoms related to metabolic dysfunction may consider undergoing this genetic test. It is also a valuable tool for genetic counseling, helping at-risk couples understand their chances of having a child with the condition. DNA Labs UAE provides this test with professional guidance and support, ensuring that individuals and families receive comprehensive information about the condition and the implications of the test results.
The ETFB Gene Acyl-CoA Multiple Dehydrogenase Deficiency (MADD) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ETFB gene, which are implicated in the development of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD). MADD, also known as Glutaric Acidemia Type II, is a rare metabolic disorder that disrupts the body's ability to break down certain fats and proteins, leading to a variety of symptoms ranging from mild to severe, including metabolic crises.
This genetic test involves the analysis of the patient's DNA to identify any abnormalities or mutations in the ETFB gene that could lead to the condition. The process is non-invasive, requiring only a blood sample from the patient. With a test cost of 4400 AED, it represents a critical step for individuals with a suspected diagnosis of MADD, enabling them to receive accurate diagnosis and appropriate management or treatment plans based on their genetic makeup.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring high accuracy and reliability of test results. By opting for the ETFB Gene Acyl-CoA Multiple Dehydrogenase Deficiency Genetic Test, patients and their families can gain valuable insights into their genetic health, paving the way for personalized medical care and interventions to manage or mitigate the effects of MADD.
The WDR27 gene plays a significant role in the development and function of the brain. Mutations in the WDR27 gene can lead to various brain disorders, which may manifest as developmental delays, intellectual disabilities, and other neurological symptoms. Recognizing the importance of early diagnosis and intervention, DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the WDR27 gene. This test is crucial for individuals who exhibit symptoms related to brain disorders or have a family history of such conditions, as it can provide a definitive diagnosis and guide treatment and management strategies.
The test is priced at 4400 AED, reflecting the comprehensive analysis and the advanced technology employed to ensure accurate results. Conducted in a state-of-the-art facility, the WDR27-related brain disorders genetic test involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab. The sample is then analyzed to identify any mutations in the WDR27 gene that could be responsible for the patient's symptoms.
By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into the genetic underpinnings of the brain disorders they are facing. This information not only aids in understanding the condition better but also opens up possibilities for targeted treatments and interventions, ultimately improving the quality of life for those affected.
